|
Bio-Techne corporation
caveolin-1 antibody (7c8) Caveolin 1 Antibody (7c8), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/caveolin-1 antibody (7c8)/product/Bio-Techne corporation Average 94 stars, based on 1 article reviews
caveolin-1 antibody (7c8) - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Boster Bio
anti caveolin 1 Anti Caveolin 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti caveolin 1/product/Boster Bio Average 90 stars, based on 1 article reviews
anti caveolin 1 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
monoclonal mouse anti caveolin 1 antibody 2297 ![]() Monoclonal Mouse Anti Caveolin 1 Antibody 2297, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/monoclonal mouse anti caveolin 1 antibody 2297/product/Becton Dickinson Average 90 stars, based on 1 article reviews
monoclonal mouse anti caveolin 1 antibody 2297 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
mouse anti-phospho-caveolin-1 ty14 antibody (611339) ![]() Mouse Anti Phospho Caveolin 1 Ty14 Antibody (611339), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse anti-phospho-caveolin-1 ty14 antibody (611339)/product/Becton Dickinson Average 90 stars, based on 1 article reviews
mouse anti-phospho-caveolin-1 ty14 antibody (611339) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
anti-caveolin-1 igg mouse monoclonal antibody 2297 ![]() Anti Caveolin 1 Igg Mouse Monoclonal Antibody 2297, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-caveolin-1 igg mouse monoclonal antibody 2297/product/Becton Dickinson Average 90 stars, based on 1 article reviews
anti-caveolin-1 igg mouse monoclonal antibody 2297 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
mouse monoclonal anti-caveolin-3 and/or anti-caveolin-1 antibody ![]() Mouse Monoclonal Anti Caveolin 3 And/Or Anti Caveolin 1 Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse monoclonal anti-caveolin-3 and/or anti-caveolin-1 antibody/product/Becton Dickinson Average 90 stars, based on 1 article reviews
mouse monoclonal anti-caveolin-3 and/or anti-caveolin-1 antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
b-catenin (ihc) 1:200 ![]() B Catenin (Ihc) 1:200, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b-catenin (ihc) 1:200/product/Becton Dickinson Average 90 stars, based on 1 article reviews
b-catenin (ihc) 1:200 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
mouse anti-tyrosine-14 phosphorylated caveolin-1 monoclonal antibody ![]() Mouse Anti Tyrosine 14 Phosphorylated Caveolin 1 Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse anti-tyrosine-14 phosphorylated caveolin-1 monoclonal antibody/product/Becton Dickinson Average 90 stars, based on 1 article reviews
mouse anti-tyrosine-14 phosphorylated caveolin-1 monoclonal antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
mouse anti-human caveolin-1 igm antibody ![]() Mouse Anti Human Caveolin 1 Igm Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse anti-human caveolin-1 igm antibody/product/Becton Dickinson Average 90 stars, based on 1 article reviews
mouse anti-human caveolin-1 igm antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Huabio Inc
anti-caveolin-1 mouse monoclonal antibody em40728 ![]() Anti Caveolin 1 Mouse Monoclonal Antibody Em40728, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-caveolin-1 mouse monoclonal antibody em40728/product/Huabio Inc Average 90 stars, based on 1 article reviews
anti-caveolin-1 mouse monoclonal antibody em40728 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Biomedical Materials Research. Part B, Applied Biomaterials
Article Title: Safety of intradiscal injection and biocompatibility of polyester amide microspheres in a canine model predisposed to intervertebral disc degeneration
doi: 10.1002/jbm.b.33579
Figure Lengend Snippet: A–G. Relative gene expression levels in non, sham‐, and PEAM‐injected, canine IVDs at 6 months follow‐up. The noninjected nuclei pulposi (NP) are set at 1. A–C. Gene expression levels of COL2A1 ( A ) and COL1A1 ( B ) were not significantly different between conditions, neither was collagen corrected for DNA ( C ). D. CASP3 expression levels were significantly lower in the AF compared with the NP. E. Expression levels of CAV1 were significantly higher in sham‐injected IVDs (NP + AF) compared with noninjected control IVDs. F. In all conditions glycosaminoglycan (GAG) corrected for DNA were significantly higher in the NP compared with the AF. G. The PEAM‐injected IVDs showed a significant higher BAX/BCL2 ratio compared with the sham‐injected IVDs. Data in A , B , D , and E are expressed as n ‐fold changes, in C and F as mean values, and in G as ratio ± standard deviation. * Indicate significant difference at a 99% confidence level
Article Snippet: Paraffin sections (5 µm) stained with hematoxylin/eosin and with picrosirius red/alcian blue were histopathologically evaluated by two independent investigators, blinded to the treatments, according to the grading scheme developed by Bergknut et al. Immunohistochemistry for
Techniques: Expressing, Injection, Standard Deviation
Journal: Cell metabolism
Article Title: Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
doi: 10.1016/j.cmet.2019.11.002
Figure Lengend Snippet: (A) Macroscopic tumor burden was assessed in Mpc1Lrig1KO, Mpc1Lrig1KO/+, and control mice at 100 days post-AOM (n=28–45 mice), ****p≤0.0001, ***p≤0.001, one-way ANOVA with multiple comparisons. Representative gross colon tumor burden and distribution are shown (ruler tick = 1mm). (B) At 100 days post-AOM, microscopic tumor grade and size assessed by pathologic grading in colons of Mpc1Lrig1KO, Mpc1Lrig1KO/+, and control mice (n=10–12), n.s.=not significant, *p≤0.05, one-way ANOVA with multiple comparisons on number of microscopic tumors per mouse. (C) Hematoxylin/Eosin and anti-β-catenin staining of control and Mpc1Lrig1KO adenomas at 100 days post-AOM, (100X, scale bars = 25μm). Black arrows indicate nuclear β-catenin. Green dashed circles indicate crypt necrosis. (D) Immunoblot of paired normal crypts (“C”) and tumor (“T”) samples from two control mice and two Mpc1Lrig1KO mice for MPC1, MPC2, and actin. Densitometry for MPC1 and MPC2, normalized to actin is shown with relative values adjusted to 100 for each control mouse normal crypt sample. (E) 100 days post-AOM, Ki67-positive nuclei as a percentage of total adenoma nuclei of Mpc1Lrig1KO and control adenomas were quantified on blinded high magnification images (n =5–7 mice, adenomas=10–20), **p≤0.01, unpaired two-tailed t-test. Representative images to the right (100X, scale bars=25μm). (F) 100 days post-AOM, cleaved caspase 3-positive nuclei of ApcLrig1KO/+Mpc1Lrig1KO and ApcLrig1KO/+ adenomas (black arrows) were quantified on blinded high magnification images (n =5–7 mice, adenomas=13–15, 100X, scale bars=25 μm), n.s.=not significant, unpaired two-tailed t-test. Green dashed circle indicates crypt necrosis and these positive nuclei were omitted. (G) At 49 days post-AOM, regions of superficial inflammation, epithelial injury with active inflammation (AI), aberrant foci, and low-grade dysplasia assessed by pathologic grading in colons of Mpc1Lrig1KO/+, Mpc1Lrig1KO/+, and control mice (n=8–10 mice), n.s.=not significant, unpaired t-test on number of microscopic lesions per mouse.
Article Snippet:
Techniques: Staining, Western Blot, Two Tailed Test
Journal: Cell metabolism
Article Title: Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
doi: 10.1016/j.cmet.2019.11.002
Figure Lengend Snippet: (A) Macroscopic tumor burden was assessed in Apc Lrig1KO/+Mpc1Lrig1KO, Apc Lrig1KO/+Mpc1Lrig1KO/+, and Apc Lrig1KO/+ mice at 90 days post-TAM (n=11–12 mice), **p≤0.01, *p≤0.05, one-way ANOVA with multiple comparisons (B) Microscopic tumor grade and size assessed by pathologic grading in the small intestine (left) and the colon (right) for ApcLrig1KO/+ Mpc1Lrig1KO and ApcLrig1KO/+ mice (n=5–7), n.s.=not significant, *p≤0.05, unpaired t-test on number of microscopic tumors per mouse. (C) Hematoxylin/Eosin, and anti-β-catenin staining of ApcLrig1KO/+ and ApcLrig1KO/+ Mpc1Lrig1KO adenomas (100X, scale bars=25 μm). Black arrows indicate nuclear β-catenin. (D) Immunoblot of paired normal crypts (“C”) and tumor (“T”) samples from two ApcLrig1KO/+ mice and two ApcLrig1KO/+Mpc1Lrig1KO mice for MPC1, MPC2, and actin. Densitometry for MPC1 and MPC2, normalized to actin is shown with relative values adjusted to 100 for each ApcLrig1KO/+ mouse normal crypt sample. (E) 90 days post-tamoxifen, Ki67-positive nuclei as a percentage of total adenoma nuclei of ApcLrig1KO/+Mpc1Lrig1KO and ApcLrig1KO/+ adenomas were quantified on blinded high magnification images (n =3–5 mice, adenomas=10–23), n.s.=not significant, unpaired two-tailed t-test. Representative images to the right (100X, scale bars=25 μm). (F) 90 days post-tamoxifen, cleaved caspase 3-positive nuclei of ApcLrig1KO/+Mpc1Lrig1KO and ApcLrig1KO/+ adenomas (black arrows) were quantified on blinded high magnification images (n =3–5 mice, adenomas = 15–16), n.s.= not significant, unpaired two-tailed t-test. Representative images to the right (100X, scale bars = 25 μm). Green dashed circle indicates crypt necrosis and these positive nuclei were omitted. (G) At 140 days post-TAM, macroscopic tumor burden per mouse in ApcVillKO/+ and ApcVillKO/+Mpc1VillKO was assessed (n=18–27,28: one small intestine was damaged during dissection and removed from analysis). *p≤0.05, unpaired t-test. (H) Microscopic tumor grade and size assessed by pathologic grading in the small intestine (left) and colon (right) of ApcVillKO/+ and ApcVillKO/+Mpc1VillKO mice (n=7–8), *p≤0.05, unpaired t-test on number of microscopic tumors per mouse.
Article Snippet:
Techniques: Staining, Western Blot, Two Tailed Test, Dissection
Journal: Cell metabolism
Article Title: Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier
doi: 10.1016/j.cmet.2019.11.002
Figure Lengend Snippet: KEY RESOURCES TABLE
Article Snippet:
Techniques: Western Blot, Recombinant, Plasmid Preparation, Protease Inhibitor, Generated, Software